Ipamorelin
A growth hormone releasing peptide that triggers a growth hormone pulse with little effect on cortisol or prolactin, at least in animal studies.
- Evidence
- Limited human research
- Half-life
- ~2 hours
- Sources
- 3 cited
Is ipamorelin FDA-approved?
Not approved by the FDA. Products sold online as "research chemicals" aren't checked for purity, sterility or dose.
Is ipamorelin banned in sport?
Banned in sport by the World Anti-Doping Agency (WADA).
Overview
Ipamorelin mimics ghrelin and binds the growth hormone secretagogue receptor. Early animal work found it more selective than older peptides like GHRP-6. In people, research is limited to a dosing study and a phase 2 trial for slow gut recovery after bowel surgery, where it didn't beat placebo.
How it works
It switches on the ghrelin receptor in the pituitary, which releases a single pulse of growth hormone.
How long does ipamorelin stay in the body?
About 2 hours in a human dosing study. The growth hormone pulse peaks about 40 minutes after a dose.
What it's studied for
- Growth hormone release
- Gut recovery after surgery (postoperative ileus)
Related: CJC-1295, Sermorelin, GHRP-2, Tesamorelin.
Sources
The studies and prescribing labels this page is written from.
- Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol, 1998 PubMed
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin in human volunteers. Pharm Res, 1999 PubMed
- Ipamorelin for postoperative ileus after bowel resection: a randomized proof-of-concept study. Int J Colorectal Dis, 2014 PubMed